文 献1）登美斉俊．物質交換．日本胎盤学会（編）. 基礎と臨床の両側面からみた胎盤学.メジカルビュー. 2019: 80-4.2）Inagaki M, Nishimura T, Nakanishi T, Shimada H, Noguchi S, Akanuma S, et al. Contribution of prostaglandin transporter OATP2A1/SLCO2A1 to placenta-to-maternal hormone signaling and labor induction. iScience 2020; 23: 101098.3）Kuroda H, Tachikawa M, Yagi Y, Umetsu M, Nurdin A, Miyauchi E, et al. Cluster of differentiation 46 is the major receptor in human blood-brain barrier endothelial cells for uptake of exosomes derived from brain-metastatic melanoma cells (SK-Mel-28). Mol Pharm 2019; 16: 292-304.4）Salomon C, Torres MJ, Kobayashi M, Scholz-Romero K, Sobrevia L, Dobierzewska A, et al. A gestational profile of placental exosomes in maternal plasma and their effects on endothelial cell migration. PLoS One 2014; 9: e98667.5）Inagaki M, Tachikawa M. Transport characteristics of placenta-derived extracellular vesicles and their relevance to placenta-to-maternal tissue communication. Chem Pharm Bull (Tokyo) 2022; 70: 324-9.6）Yang Z, Philips JD, Doty RT, Giraudi P, Ostrow JD, Tiribelli C, et al. Kinetics and specificity of feline leukemia virus subgroup C receptor (FLVCR) export function and its dependence on hemopexin. J Biol Chem 2010; 285: 28874-82.7）Vargas A, Zhou S, Éthier-Chiasson M, Flipo D, Lafond J, Gilbert C, et al. Syncytin proteins incorporated in placenta exosomes are important for cell uptake and show variation in abundance in serum exosomes from patients with preeclampsia. FASEB J 2014; 28: 3703-19.8）Uchida Y, Tachikawa M, Obuchi W, Hoshi Y, Tomioka Y, Ohtsuki S, et al. A study protocol for quantitative targeted absolute proteomics (QTAP) by LC-MS/MS: application for inter-strain differences in protein expression levels of transporters, receptors, claudin-5, and marker proteins at the blood-brain barrier in ddY, FVB, and C57BL/6J mice. Fluids Barriers CNS 2013; 10: 21.9）Dehouck MP, Tachikawa M, Hoshi Y, Omori K, Maurage CA, Strecker G, et al. Quantitative targeted absolute proteomics for better characterization of an in vitro human blood-brain barrier model derived from hematopoietic stem cells. Cells 2022; 11: 3963.10）Puris E, Gynther M, Auriola S, Huttunen KM. L-Type amino acid transporter 1 as a target for drug delivery. Pharm Res 2020; 37: 88.11）Nishimura T, Takanohashi T, Tomi M, Horikoshi M, Higuchi K, Sai Y, et al. Evaluation of rat in vivo fetal-to-maternal transfer clearances of various xenobiotics by umbilical perfusion. J Pharm Sci 2013; 102: 3356-63.12）Kurosawa K, Chiba K, Noguchi S, Nishimura T, Tomi M. Development of a pharmacokinetic model of transplacental transfer of metformin to predict in vivo fetal exposure. Drug Metab Dispos 2020; 48: 1293-302.141
元のページ ../index.html#155